| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $99.6M | +19.2% |
| Cost of Revenue | $38.0M | +15.9% |
| Gross Profit | $61.6M | +21.3% |
| R&D Expense | $6.0M | +21.3% |
| SG&A Expense | $18.4M | -26.4% |
| Operating Income | $7.7M | +238.0% |
| Pre-tax Income | $8.9M | +279.3% |
| Income Tax | $305K | — |
| Net Income | $8.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.5M | +63.6% |
| Inventory | $9.2M | -36.7% |
| Current Assets | $64.1M | +29.4% |
| Total Assets | $68.3M | +24.2% |
| Current Liabilities | $17.9M | -13.0% |
| Total Liabilities | $22.2M | -16.3% |
| Stockholders' Equity | $46.1M | +62.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.1M | +70.1% |
| Investing Cash Flow | -$143K | +0.0% |
| Financing Cash Flow | $5.4M | +6065.6% |
| +273.1% |
| EPS (Basic) | $0.11 | +257.1% |
| EPS (Diluted) | $0.11 | +257.1% |